IQVIA™ Real-World Insights Bibliography

Empagliflozin is Associated with Lower Risk of Cardiovascular Events and All-Cause Mortality in Routine Care in East Asia: Results from the EMPRISE Study
Author(s): Dae Jung Kim (1), Wayne H-H Sheu (2), Wook-Jin Chung (3), Daisuke Yabe (4-7), Kyoung Hwa Ha (1), Masaomi Nangaku (8), Elise Chia-Hui Tan (9), Koichi Node (10), Atsutaka Yasui (11), Weiyu Lei (12), Sunwoo Lee (13), Laura Saarelainen (14), Anouk Deruaz-Luyet (15), Moe H. Kyaw (16) and Yutaka Seino (4,17), EMPRISE East Asia Study Group
Affiliations(s): "1 Department of Endocrinology and Metabolism, Ajou University School of Medicine, Suwon, South Korea 2 Division of Endocrinology and Metabolism, Taipei Veterans General Hospital, Taipei, Taiwan 3 Department of Cardiovascular Medicine, Gachon University Gil Medical Center, Incheon, South Korea 4 Kansai Electric Power Medical Research Institute, Kobe, Japan 5 Department of Diabetes, Metabolism and Endocrinology/Department of Rheumatology and Clinical Immunology, Gifu University Graduate School of Medicine, Gifu, Japan 6 Center for Healthcare Information Technology, Tokai National Higher Education and Research System, Nagoya, Japan 7 Division of Metabolism and Molecular Medicine, Kobe University Graduate School of Medicine, Kobe, Japan 8 Division of Nephrology and Endocrinology, The University of Tokyo, Tokyo, Japan 9 National Research Institute of Chinese Medicine, Ministry of Health and Welfare, Taipei, Taiwan, and Institute of Hospital and Healthcare Administration, National Yang-Ming University, Taipei, Taiwan 10 Department of Cardiovascular Medicine, Saga University, Saga, Japan 11 Nippon Boehringer Ingelheim Co. Ltd., Tokyo, Japan 12 Boehringer Ingelheim Taiwan Ltd., Taipei, Taiwan 13 Boehringer Ingelheim Korea Ltd, Seoul, Korea 14 IQVIA, Espoo, Finland 15 Boehringer Ingelheim International GmbH, Ingelheim, Germany 16 Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, CT, USA 17 Kansai Electric Power Hospital, Osaka, Japan "
Publication(s):  "JDI journal Virtual Conference: ACC, May 2021"
Document Type(s): Article,
Countries: Japan, Korea, Taiwan,
Click here for the abstract
C:
Y:
Cardiovascular disease, Diabetes, Drug safety, Drug Utlization Study,
2023
  L:
A:
English
Clinical setting: hospital, Clinical setting: Primary care, Retrospective cohort analysis,
  Add to report
 
 
Cost-effectiveness analysis of ranibizumab biosimilar for neovascular age-related macular degeneration in Japan
Author(s): Yasuo Yanagi 1, Kanji Takahashi 2, Tomohiro Iida 3, Fumi Gomi 4, Junko Morii 5, Eriko Kunikane 6, Taiji Sakamoto 7 (rwesheorj 5)
Affiliations(s): 1) Department of Ophthalmology and Microtechnology, Yokohama City University, Kanagawa, Japan 2) Department of Ophthalmology, Kansai Medical University, Osaka, Japan 3) Department of Ophthalmology, Tokyo Women's Medical University School of Medicine, Tokyo, Japan 4) Department of Ophthalmology, Hyogo Medical University, Hyogo, Japan 5) IQVIA Solutions Japan, K.K., Tokyo, Japan 6) Senju Pharmaceutical Co., Ltd., Osaka, Japan 7) Department of Ophthalmology, Kagoshima University Graduate School of Medical and Dental Sciences, Kagoshima, Japan
Publication(s):  Ophthalmology and Therapy
Document Type(s): Article,
Countries: Japan,
Click here for the abstract
C:
Y:
Vascular disease,
2023
  L:
A:
English
Cost analysis, Cost effectiveness,
  Add to report
 
 
Assessing definitions and incentives adopted for innovation for pharmaceutical products in five high-income countries: a systematic literature review
Author(s): Naohiko Wakutsu 1, Emi Hirose 2, Naohiro Yonemoto 3, Sven Demiya 4 (rwesheorj 4)
Affiliations(s): 1) Graduate School of Economics, Nagoya City University, Nagoya, Japan 2) Health & Value, Pfizer Japan Inc., Tokyo, Japan. emi.hirose@pfizer.com 3) Health & Value, Pfizer Japan Inc., Tokyo, Japan 4) IQVIA Solutions Japan K.K., Tokyo, Japan
Publication(s):  Pharmaceutical Medicine
Document Type(s): Article,
Countries: France, Germany, Japan, UK, USA,
Click here for the abstract
C:
Y:
Miscellaneous,
2023
  L:
A:
English
Literature Review,
  Add to report
 
 
Patient burden associated with treatment-resistant or unexplained chronic cough - a qualitative study based on focus group interviews
Author(s): Naoya Ueda 1, Anzu Yakushiji 2, Shigeru Tokita 1, Takekazu Kubo 1 (rwesheorj 2)
Affiliations(s): 1) MSD Co., Ltd., Medical Affairs 2) IQVIA Solutions Japan K.K., Tokyo, Japan
Publication(s):  Progress in Medicine
Document Type(s): Article,
Countries: Japan,
Click here for the abstract
C:
Y:
Respiratory disease,
2023
  L:
A:
Japanese
Burden of illness, Patient questionnaire,
  Add to report
 
 
Identification and management of connective tissue disease-associated interstitial lung disease: evidence-based Japanese consensus statements
Author(s): Masataka Kuwana 1, Masashi Bando 2, Yutaka Kawahito 3, Shinji Sato 4, Takafumi Suda 5, Yasuhiro Kondoh 6; CTD-ILD Delphi Collaborators (rwesheorj A)
Affiliations(s): 1) Department of Allergy and Rheumatology, Nippon Medical School Graduate School of Medicine, Tokyo, Japan. 2) Division of Pulmonary Medicine, Department of Medicine, Jichi Medical University, Tochigi, Japan. 3) Inflammation and Immunology, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan. 4) Division of Rheumatology, Department of Internal Medicine, Tokai University School of Medicine, Isehara, Japan. 5) Second Division, Department of Internal Medicine, Hamamatsu University School of Medicine, Hamamatsu, Japan. 6) Department of Respiratory Medicine and Allergy, Tosei General Hospital, Seto, Japan.
Publication(s):  Expert Review of Respiratory Medicine
Document Type(s): Article,
Countries: Japan,
Click here for the abstract
C:
Y:
Respiratory disease,
2023
  L:
A:
English
Literature Review, Survey research,
  Add to report
 
 
Exploring current practice, knowledge, and challenges of sexually transmitted infection/HIV management and pre-exposure prophylaxis among Japanese health care professionals: a cross-sectional web survey
Author(s): Mayuko Kamakura 1, Daisuke Fukuda 1, Naho Kuroishi 1, Dilinuer Ainiwaer 2, Junko Hattori 1 (rwesheorj 2)
Affiliations(s): 1) Medical Affairs, MSD K.K., Tokyo, Japan 2) IQVIA Solutions Japan K.K., Tokyo, Japan
Publication(s):  AIDS Patient Care and STDs
Document Type(s): Article,
Countries: Japan,
Click here for the abstract
C:
Y:
HIV AIDS,
2023
  L:
A:
English
Survey research,
  Add to report
 
 
Comparison of depression trends in the Japanese and US populations before and during the COVID-19 pandemic: a retrospective observational study using real-world data
Author(s): Sven Demiya 1, Shujiro Takeno 1, Louis P. Watanabe 1, Wen Shi Lee 1, Yuri Sakai 1, Todd D. Taylor 1, Seok-Won Kim 1 (rwesheorj 1)
Affiliations(s): 1) IQVIA Solutions Japan KK, Tokyo Japan
Publication(s):  Value & Outcomes Spotlight
Document Type(s): Article,
Countries: Japan, USA,
Click here for the abstract
C:
Y:
Mental health,
2023
  L:
A:
English
Database Study, Observational study, Retrospective database analysis,
  Add to report
 
 
Cost of illness: estimating direct healthcare costs related to obesity in a Japanese clinical setting
Author(s): Riku Ota 1, Koki Idehara 2, Hiroyuki Matsuda 2, Ronald Filomeno 2, J Baker-Knight 3 (rwesheorj 2)
Affiliations(s): 1) Novo Nordisk Pharma Ltd., Nerima, 13, Japan 2) IQVIA Solutions Japan K.K., Minato-ku, Tokyo, Japan 3) Novo Nordisk, 2900, Denmark
Publication(s):  ISPOR
Value in Health
Document Type(s): Abstract, Conference, Poster, Presentation,
Countries: Japan,
Click here for the abstract
C:
Y:
Endocrinology,
2023
  L:
A:
English
Cost of illness, Database Study,
  Add to report
 
 
Real-world trends of patients with syphilis in Japan using integrated data of IQVIA Claims, JAST data and DeSC database
Author(s): Yuki Kado 1, Seok-Won Kim 2, T Ishii 3 (rwesheorj 1-3)
Affiliations(s): 1) IQVIA Solutions Japan, Minato-ku, 13, Japan 2) IQVIA Solutions Japan, Minato, 13, Japan 3) IQVIA Solutions Japan, Minato-ku, Tokyo, Japan
Publication(s):  ISPOR
Value in Health
Document Type(s): Abstract, Conference, Poster, Presentation,
Countries: Japan,
Click here for the abstract
C:
Y:
Infectious disease,
2023
  L:
A:
English
Database Study,
  Add to report
 
 
Real-world clinical practice of pulmonary arterial hypertension in Japan: Insights from a large administrative database
Author(s): Junichi Omura 1, Kazuki Kitahara 1, Masashi Takano 1, Koki Idehara 2, Seok-Won Kim 2 (rwesheorj 2)
Affiliations(s): 1) Medical Affairs Janssen Pharmaceutical K. K. Tokyo Japan 2) RWES/HEOR IQVIA Solutions Japan K. K. Tokyo Japan
Publication(s):  Pulmonary Circulation
Document Type(s): Article,
Countries: Japan,
Click here for the abstract
C:
Y:
Cardiovascular disease,
2023
  L:
A:
English
Database Study, Retrospective cohort analysis,
  Add to report
 
 
 1 of 9 Next Page Last Page